Publicaciones en las que colabora con Lorena Alonso Alconada (13)

2020

  1. Circulating Tumor Cells Characterization Revealed TIMP1 as a Potential Therapeutic Target in Ovarian Cancer

    Cells, Vol. 9, Núm. 5

  2. Genomic profiling of uterine aspirates and cfDNA as an integrative liquid biopsy strategy in endometrial cancer

    Journal of Clinical Medicine, Vol. 9, Núm. 2

2017

  1. Predicting outcome and therapy response in mCRC patients using an indirect method for CTCs detection by a multigene expression panel: A multicentric prospective validation study

    International Journal of Molecular Sciences, Vol. 18, Núm. 6

2015

  1. Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer

    International Journal of Cancer, Vol. 136, Núm. 8, pp. 1863-1873

  2. Nidogen 1 and Nuclear Protein 1: novel targets of ETV5 transcription factor involved in endometrial cancer invasion

    Clinical and Experimental Metastasis, Vol. 32, Núm. 5, pp. 467-478

2014

  1. ETV5 transcription program links BDNF and promotion of EMT at invasive front of endometrial carcinomas

    Carcinogenesis, Vol. 35, Núm. 12, pp. 2679-2686

  2. Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer

    Molecular Cancer, Vol. 13, Núm. 1

2013

  1. Zoledronic acid as an antimetastatic agent for different human tumor cell lines

    Anticancer Research, Vol. 33, Núm. 12, pp. 5295-5300

2012

  1. A logistic model for the detection of circulating tumour cells in human metastatic colorectal cancer

    Journal of Cellular and Molecular Medicine, Vol. 16, Núm. 10, pp. 2342-2349

  2. ETV5 cooperates with LPP as a sensor of extracellular signals and promotes EMT in endometrial carcinomas

    Oncogene, Vol. 31, Núm. 45, pp. 4778-4788

  3. Molecular characterization of circulating tumor cells in human metastatic colorectal cancer

    PLoS ONE, Vol. 7, Núm. 7

  4. Tumor invasion and oxidative stress: Biomarkers and therapeutic strategies

    Current Molecular Medicine, Vol. 12, Núm. 6, pp. 746-762

2011

  1. High-risk endometrial carcinoma profiling identifies TGF-β1 as a key factor in the initiation of tumor invasion

    Molecular Cancer Therapeutics, Vol. 10, Núm. 8, pp. 1357-1366